EmSense launches in-home neuroscience panel

Respondents who sign up are sent the firm’s EmBand technology which measures cognitive engagement, positive or negative emotional responses and other bio-sensory response metrics.

The firm said that the panel currently contains more than 2,000 households but it plans to increase that number to more than 25,000 by the end of the year. Eventually EmSense said it aims to recruit a six figure number and launch similar panels in the UK and Japan.

EmSense said that its EmBand technology can be prepared in less than a minute before respondents take part in online tests.

Benefits of the in-home testing, according to EmSense, include more representative sampling and faster study completion time.